 |
Top Story
2015 Medicaid Drug Price Controls: A 1980s Throwback?
Reading the various reports of the Rx industry jousting with state Medicaid programs that are struggling with the costs of the new Hep C, hypertension, MS, cancer, and other “specialty drugs”, Tom Norton can’t help but think about that old adage: The Past is Prologue
...Read more |
 |
Adherence
“Activating” the Patient
One clear missive from the Patient Adherence and Access Summit this summer is that adherence remains an untapped opportunity. But the current mindset of “compliance” and “adherence” won’t cut it. “Engaging” and “activating” patients is the new mode of thinking and will be necessary to unlock the potential value. Casey McDonald reports
...Read more |
Find new partners at the AAPS Annual Meeting & Exposition!
The largest, global business forum for pharmaceutical and biopharmaceutical manufacturers, distributors, and service providers is happening October 26-28, 2016, in Orlando, Florida.
Special registration pricing available for full access to the 80,000 net square feet of exposition floor space.
Visit
 www.aaps.org/annualmeeting for complete information. |
Pricing
New Payment Models: It's Time to Move
Fundamental changes in the US access and reimbursement landscape are accelerating for the vast majority of public and commercial stakeholders. Commercial success for pharma brands now demands proactive strategies and interventions, writes Stacie Heller and Peter Weissberg
...Read more |
Pharmaceutical Executive E-Book – Coming November 2015: Securing the Global Supply Chain: Strategies for Operational Excellence
Key Topics include:
- Compliance Groundswell: What are the New Rules and Regulator Expectations?
- Global Dynamics of Risk: Can Technology Keep Pace?
- Benchmarking Best Practices: Upgrading Company Performance Culture
- What's Ahead: How Logistics and Distribution Science will Shape Tomorrow's Supply Chain
 Contact your sales rep for more information and to secure your sponsorship. |
Comment
Pharma Must Move Beyond Cooperation to True Collaboration
Collaboration can lead to real innovation and change, but coordination and cooperation can just lead to more of the same thing, writes Mike Straw
...Read more |
Pharmaceutical Executive E-Book – Coming October 2015: Changing Contours of Commercialization: Impact of US Health Reform on Patients, Payers and Providers
Key Topics include:
- Phase-in of the 2010 Affordable Care Act: Five stages of pain and plenty
- Pay for Performance and Shared Savings Programs – Implications for Pharma Marketers
- How ACO models are driving physician and provider decision-making
- Primer on policies and financial drivers impacting payer markets – MLR, MSSP, CMS etc.
 Contact your sales rep for more information and to secure your sponsorship. |
 |
 //William N. Scheffel, Executive Vice President and Chief Financial Officer of Centene Corporation (St. Louis, MO) has advised the company of his intention to retire in early 2016. //BioPharmX Corporation (Menlo Park, CA) appointed Greg Kitchener as Vice President of Finance and Chief Financial Officer. //BioMark Diagnostics Inc. (Vancouver, British Columbia) appointed Thomas Malcolm, Ph.D., as Chief Scientific Officer and Head of U.S. Operations. //Wendy Yarno was elected as Chairman of the Board of Directors of Aratana Therapeutics (Kansas City, KS). //NanoSmart Pharmaceuticals (Laguna Hills, CA) recruited Ms. Kay Metis as Vice President of Strategic Alliances. // |
|
No Access, No Business: The rocky road to Market Access Excellence
Live Webinar: Tuesday, 1 September 2015 at 11 am EDT / 4 pm BST / 5 pm CEST No access = no business!
Market Access needs to be the most important function in your organization. Transforming this function to fulfill that key role is difficult, but possible. Learn in our webcast how to achieve true Excellence in Market Access and be ready for future challenges.
 Register Free |
|
